| 1 |
Ries T, Siemonsen S, Grzyska U, et al. Abciximab is a safe rescue therapy in thromboembolic events complicating cerebral aneurysm coil embolization: single center experience in 42 cases and review of the literature[J]. Stroke,2009,40(5):1750-1757. doi: 10.1161/STROKEAHA.108.539197. |
| 2 |
冯雷. 替罗非班联合尿激酶血管内超选择溶栓的实验及临床研究[D]. 南方医科大学,2012.
|
| 3 |
Januzzi JJ, Snapinn SM, Dibattiste PM, et al. Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial[J]. Circulation,2002,105(20):2361-2366.
|
| 4 |
Effects of platelet glycoprotein Ⅱb/Ⅲa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis[J]. Circulation,1997,96(5):1445-1453.
|
| 5 |
Boersma E, Harrington RA, Moliterno DJ, et al. Platelet glycoprotein Ⅱb/Ⅲa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials[J]. Lancet,2002,359(9302):189-198.
|
| 6 |
Rebello SS, Driscoll EM, Lucchesi BR. TP-9201, a glycoprotein Ⅱb/Ⅲa platelet receptor antagonist, prevents rethrombosis after successful arterial thrombolysis in the dog[J]. Stroke,1997,28(9):1789-1796.
|
| 7 |
Abumiya T, Fitridge R, Mazur C, et al. Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia[J]. Stroke,2000,31(6):1402-1409, 1409-1410.
|
| 8 |
Yi HJ, Gupta R, Jovin TG, et al. Initial experience with the use of intravenous eptifibatide bolus during endovascular treatment of intracranial aneurysms[J]. AJNR Am J Neuroradiol,2006,27(9):1856-1860.
|
| 9 |
Kang HS, Kwon BJ, Roh HG, et al. Intra-arterial tirofiban infusion for thromboembolism during endovascular treatment of intracranial aneurysms.[J]. Neurosurgery,2008,63(2):230-238. doi: 10.1227/01.NEU.0000320440.85178.CC. |
| 10 |
Cho YD, Lee JY, Seo JH, et al. Intra-arterial tirofiban infusion for thromboembolic complication during coil embolization of ruptured intracranial aneurysms.[J]. Eur J Radiol,2012,81(10):2833-2838. doi: 10.1016/j.ejrad.2011.11.023. |
| 11 |
Jeon JS, Sheen SH, Hwang G, et al. Intraarterial tirofiban thrombolysis for thromboembolisms during coil embolization for ruptured intracranial aneurysms[J]. J Cerebrovasc Endovasc Neurosurg,2012,14(1):5-10. doi: 10.7461/jcen.2012.14.1.5. |
| 12 |
Lee LY, Debois W, Krieger KH, et al. The effects of platelet inhibitors on blood use in cardiac surgery[J]. Perfusion,2002,17(1):33-37.
|
| 13 |
Servoss SJ, Wan Y, Snapinn SM, et al. Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial[J]. Am J Cardiol,2004,93(7):843-847.
|
| 14 |
Bruening R, Mueller-Schunk S, Morhard D, et al. Intraprocedural thrombus formation during coil placement in ruptured intracranial aneurysms: treatment with systemic application of the glycoprotein Ⅱb/Ⅲa antagonist tirofiban[J]. AJNR Am J Neuroradiol,2006,27(6):1326-1331.
|
| 15 |
|
| 16 |
Walsh RD, Barrett KM, Aguilar MI, et al. Intracranial hemorrhage following neuroendovascular procedures with abciximab is associated with high mortality: a multicenter series[J]. Neurocrit Care,2011,15(1):85-95. doi: 10.1007/s12028-010-9338-1. |
| 17 |
Chalouhi N, Jabbour P, Kung D, et al. Safety and efficacy of tirofiban in stent-assisted coil embolization of intracranial aneurysms[J]. NeuroSurgery,2012,71(3):710-714. doi: 10.1227/NEU.0b013e31826213f9. |
| 18 |
Chalouhi N, Zanaty M, Starke R, et al. O-022 A New Protocol for Anticoagulation with Tirofiban during Stenting of Intracranial Aneurysms[J]. J Neurointerv Surg,2014, 6:A11-A12. doi: 10.1136/neurintsurg-2014-011343.22 |
| 19 |
|
| 20 |
Junghans U, Seitz RJ, Aulich A, et al. Bleeding risk of tirofiban, a nonpeptide GPⅡb/Ⅲa platelet receptor antagonist in progressive stroke: an open pilot study.[J]. Cerebrovasc Dis,2001,12(4):308-312.
|
| 21 |
Kim JW, Jeon P, Kim GM, et al. Local intraarterial tirofiban after formation of anterograde flow in patients with acute ischemic stroke: preliminary experience and short term follow-up results.[J]. Clin Neurol Neurosurg, 2012,114(10):1316-1319. doi: 10.1016/j.clineuro.2012.04.022. |
| 22 |
Seitz RJ, Hamzavi M, Junghans U, et al. Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations[J]. Stroke,2003,34(8):1932-1935.
|
| 23 |
Mangiafico S, Cellerini M, Nencini P, et al. Intravenous glycoprotein Ⅱb/Ⅲa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke[J]. AJNR Am J Neuroradiol,2005,26(10):2595-2601.
|
| 24 |
Philipps J, Thomalla G, Glahn J, et al. Treatment of progressive stroke with tirofiban--experience in 35 patients[J]. Cerebrovasc Dis,2009,28(5):435-438. doi: 10.1159/000235987. |
| 25 |
Kwon JH, Shin SH, Weon YC, et al. Intra-arterial adjuvant tirofiban after unsuccessful intra-arterial thrombolysis of acute ischemic stroke: preliminary experience in 16 patients[J]. Neuroradiology,2011,53(10):779-785. doi: 10.1007/s00234-011-0939-y. |
| 26 |
Baik SK, Oh SJ, Park KP, et al. Intra-arterial tirofiban infusion for partial recanalization with stagnant flow in hyperacute cerebral ischemic stroke[J]. Interv Neuroradiol,2011,17(4):442-451.
|
| 27 |
|
| 28 |
王婧，袁晋青. 血小板功能检测指导下个体化抗血小板聚集治疗的研究进展[J]. 中华临床医师杂志(电子版),2013(12):5507-5509.
|
| 29 |
Bonello L, Tantry US, Marcucci R, et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate[J]. J Am Coll Cardiol,2010,56(12):919-933. doi: 10.1016/j.jacc.2010.04.047. |